Karabay, Oğuz
(LIPPINCOTT WILLIAMS & WILKINS, 2012)
Conclusion According to our results, for HBe antigen-negative CHB cases, the response rate during the sixth month after the treatment with PegIFN was determined to be similar to 17%. No difference was found between the ...